Cerus Corporation   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Concord CA United States (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2012
NCT01711346
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Cerus Corporation